Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Curr Eye Res. 2022 Mar 28;47(7):1034–1042. doi: 10.1080/02713683.2022.2053166

Table 3.

Aflibercept Release Characteristics from DDS.

Formulation Estimated Total Drug Load (ug) Initial Burst (first 24 hours) (%) E.E. of Particles into Hydrogel (%) Release Rate after 7 days (ug/day) Release time achieved (days) Final Percent Released (%)
AFL-DDS 277.9 ± 8.4 24.1 ± 4.3 74.9 ± 2.5 0.37 (R2 = 0.88) 203 69.4 ± 6.8
Combo-DDS 267.4 ± 2.2 20.2 ± 2.7 75.6 ± 0.4 0.58 (R2 = 0.95) 224 89.7 ± 5.1

Data represented by mean ± SEM (n=3).